L-glutamic acid derivatives
US5013738A · kind A · utility
15Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 1990 |
| Grant date | May 7, 1991 |
| Priority date | — |
| Expiry date | Apr 18, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted pyrimidin-5-yl derivatives of L-glutamic acid are anti-neoplastic agents. A typical embodiment is N-{4-[6-(2,6-diamino-4-hydroxypyrimidin-5-yl)hex-1-en-3-yl]benzoyl}-L-glut amic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.